Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 35 (PPIAP35) is a non-coding genomic locus classified as a pseudogene—a DNA sequence similar to the functional peptidylprolyl isomerase A (PPIA) gene, but lacking protein-coding potential and functional activity[7][3]. Like other pseudogenes, PPIAP35 may be transcribed into non-coding RNA, but there is no evidence that it produces an active protein or serves as a molecular drug target. Some PPIA-related pseudogenes are reported to regulate their parental gene by acting as competing endogenous RNAs (ceRNAs), but specific functional annotation or disease association for PPIAP35 is currently not established[4][6]. Key points: - PPIAP35 is a pseudogene, not a protein-coding gene[7][3]. - Not a therapeutic target, receptor, enzyme, or transporter. - No known drugs, mechanisms of action, or biomarker roles. - No clinical or pharmacological utility reported. - If you require information about the functional enzyme "Peptidylprolyl isomerase A" (PPIA, also called cyclophilin A), refer specifically to the PPIA gene and protein, not the pseudogene PPIAP35[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 35 (PPIAP35).